This strongly supports the idea of using an image-derived and tumor-specific “in-situ” measurement of the heterogoenous uPAR expression for treatment stratification, which is exactly what uPAR-PET is capable of doing as demonstrated in our previous study17. Here, PLAUR is linked to neoplasm.